Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Neoplasms 2Stomach Neoplasms 1Sarcoma, Kaposi 1Pancreatic Neoplasms 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liposarcoma 1Hodgkin Disease 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Castleman Disease 1Carcinoma, Renal Cell 1

Interventions

Trabectedin 2Doxorubicin 2sodium thiosulfate 1plitidepsin 1milademetan 1avelumab 1atezolizumab 1X-Rays 1TTI-621 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Platinum 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Immunoenzyme Techniques 1Hyperthermic Intraperitoneal Chemotherapy 1Gene Expression Profiling 1Cytoreduction Surgical Procedures 1Cyproheptadine 1Cisplatin 1Blotting, Western 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Liposarcoma × Nelfinavir × Clear all
NCT00233948 2015-04-01

Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma

City of Hope Medical Center

Phase 1/2 Terminated
29 enrolled 7 charts
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡